Avid Bioservices, Inc. 8-K

0001683168-24-007200.txt : 20241017 0001683168-24-007200.hdr.sgml : 20241017 20241017164552 ACCESSION NUMBER: 0001683168-24-007200 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241016 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20241017 DATE AS OF CHANGE: 20241017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avid Bioservices, Inc. CENTRAL INDEX KEY: 0000704562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953698422 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32839 FILM NUMBER: 241378096 BUSINESS ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 BUSINESS PHONE: 714.508.6100 MAIL ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 FORMER COMPANY: FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE CORP/DE/ DATE OF NAME CHANGE: 19970924 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 8-K 1 avid_8k.htm FORM 8-K Avid Bioservices, Inc. 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 16, 2024

AVID BIOSERVICES, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-32839	95-3698422
(State of other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

14191 Myford Road, Tustin, California 92780

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (714) 508-6100

__________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
	☐	Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.001 par value per share	CDMO	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Compensatory Arrangements of Certain Officers

2018 Omnibus Incentive Plan

On October 16, 2024, at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Avid Bioservices, Inc. (the “Company”), the stockholders of the Company approved a second amendment (the “Second Amendment”) to the Company’s 2018 Omnibus Incentive Plan to increase the number of shares available for grant thereunder by 3,800,000 (as so amended, the “Amended 2018 Plan”).

The Second Amendment previously had been approved by the Compensation Committee of the Company’s Board of Directors on August 21, 2024, subject to stockholder approval. The Second Amendment became effective immediately upon stockholder approval at the Annual Meeting.

The summary of the Second Amendment is qualified in its entirety by reference to the full text of the Second Amendment, a copy of which is attached as Exhibit A to the Company’s Definitive Proxy Statement for its 2024 Annual Stockholders Meeting filed with the Securities and Exchange Commission on August 28, 2024 (the “2024 Definitive Proxy Statement”) and incorporated herein by this reference. In addition, a more detailed summary of the Amended 2018 Plan can be found in such 2024 Definitive Proxy Statement, which is incorporated herein by this reference.

2010 Employee Stock Purchase Plan

Also on October 16, 2024, at the Annual Meeting, the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s 2010 Employee Stock Purchase Plan, as amended, to remove its automatic termination provision (as so amended, the “Amended ESPP”).

The Amendment previously had been approved by the Compensation Committee of the Company’s Board of Directors on May 30, 2024, subject to stockholder approval. The Amendment became effective immediately upon stockholder approval at the Annual Meeting.

This summary of the Amendment is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit B to the Company’s 2024 Definitive Proxy Statement and incorporated herein by this reference. In addition, a more detailed summary of the Amended ESPP can be found in such 2024 Definitive Proxy Statement, which is incorporated herein by this reference.

Item 5.07

Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, of the 63,795,108 shares of the Company’s common stock outstanding (as of the record date of August 20, 2024) and entitled to vote, 50,991,631 shares were present in-person virtually or represented by proxy, representing approximately 80% of the total outstanding shares entitled to vote. The final voting results of each proposal voted on at the Annual Meeting are set forth below. For more information about the proposals set forth below, please refer to the Company’s 2024 Definitive Proxy Statement.

2

Proposal No. 1: Election of Directors

The Company’s stockholders elected each of the seven nominees named below to serve on the Company’s Board of Directors until the Company’s 2025 Annual Meeting of Stockholders. Election of each director required approval by a plurality of the votes cast and thus votes against were not applicable. The votes were as follows:

Nominee	Votes For	Votes Withheld	Broker Non-Votes
Esther M. Alegria, Ph.D.	39,065,262	3,386,725	8,539,644
Joseph Carleone, Ph.D.	40,102,583	2,349,404	8,539,644
Nicholas S. Green	41,729,893	722,094	8,539,644
Richard B. Hancock	38,727,239	3,724,748	8,539,644
Catherine J. Mackey, Ph.D.	39,063,517	3,388,470	8,539,644
Gregory P. Sargen	38,981,723	3,470,264	8,539,644
Jeanne A. Thoma	40,348,375	2,103,612	8,539,644

Proposal No. 2: Ratification of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 30, 2025. The votes were as follows:

Votes For		Votes Against		Abstain
49,045,821		1,725,042		220,768

Proposal No. 3: To Approve, on an Advisory Basis, the Compensation of the Named Executive Officers

The Company’s stockholders approved, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s Definitive Proxy Statement for its 2024 Annual Meeting of Stockholders. The votes were as follows:

Votes For		Votes Against		Abstain		Broker Non-Votes
39,680,899		2,510,504		260,584		8,539,644

Proposal No. 4: To Approve an Amendment to the Company’s 2018 Omnibus Incentive Plan

The Company’s stockholders approved an amendment to the Company’s 2018 Omnibus Incentive Plan to increase the number of shares available for grant thereunder by 3,800,000. The votes were as follows:

Votes For		Votes Against		Abstain		Broker Non-Votes
39,422,442		2,834,763		194,782		8,539,644

Proposal No. 5: To Approve an Amendment to the Company’s 2010 Employee Stock Purchase Plan

The Company’s stockholders approved an amendment to the Company’s 2010 Employee Stock Purchase Plan to remove its automatic termination provision. The votes were as follows:

Votes For		Votes Against		Abstain		Broker Non-Votes
41,785,365		472,242		194,380		8,539,644

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVID BIOSERVICES, INC.


Date: October 17, 2024	By:	/s/ Daniel R. Hart
		Daniel R. Hart
		Chief Financial Officer

4

EX-101.SCH 2 cdmo-20241016.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 cdmo-20241016_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 cdmo-20241016_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Oct. 16, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 16, 2024
Entity File Number	001-32839
Entity Registrant Name	AVID BIOSERVICES, INC.
Entity Central Index Key	0000704562
Entity Tax Identification Number	95-3698422
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	14191 Myford Road
Entity Address, City or Town	Tustin
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92780
City Area Code	(714)
Local Phone Number	508-6100
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	CDMO
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://avidbio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports avid_8k.htm cdmo-20241016.xsd cdmo-20241016_lab.xml cdmo-20241016_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "avid_8k.htm": { "nsprefix": "CDMO", "nsuri": "http://avidbio.com/20241016", "dts": { "inline": { "local": [ "avid_8k.htm" ] }, "schema": { "local": [ "cdmo-20241016.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "cdmo-20241016_lab.xml" ] }, "presentationLink": { "local": [ "cdmo-20241016_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://avidbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-10-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "avid_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-10-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "avid_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001683168-24-007200-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-24-007200-xbrl.zip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Ƹ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avid_8k_htm.xml IDEA: XBRL DOCUMENT 0000704562 2024-10-16 2024-10-16 iso4217:USD shares iso4217:USD shares false 0000704562 8-K 2024-10-16 AVID BIOSERVICES, INC. DE 001-32839 95-3698422 14191 Myford Road Tustin CA 92780 (714) 508-6100 false false false false Common Stock, $0.001 par value per share CDMO NASDAQ false